| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/09/1998 | US5763406 Method for the treatment of conditions caused by herpes virus infections |
| 06/09/1998 | US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders |
| 06/04/1998 | WO1998023625A1 Synthetic glycoamines, methods for their use that affect cell |
| 06/04/1998 | WO1998023588A1 Metalloproteinase inhibitors |
| 06/04/1998 | WO1998004294A3 Radiolabeled annexins |
| 06/04/1998 | WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers |
| 06/04/1998 | CA2272992A1 Synthetic glycoamines, methods for their use that affect cell |
| 06/03/1998 | EP0845003A1 Novel opioid peptides |
| 06/03/1998 | EP0845002A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 06/03/1998 | EP0779815A4 Surface-modifying copolymers having cell adhesion properties |
| 06/03/1998 | CN1183726A Synthetic cryptophycins |
| 06/02/1998 | US5760285 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
| 06/02/1998 | US5760235 Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof |
| 06/02/1998 | US5760019 Inhibit protease enzymes |
| 06/02/1998 | US5760003 Hemoregulatory peptides |
| 06/02/1998 | US5760002 Analgesics |
| 06/02/1998 | US5760001 Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 06/02/1998 | US5759996 Reduce bone resorption, angiogenesis, and restenosis |
| 06/02/1998 | US5759865 Solid phase synthesis of peptide-like compounds |
| 06/02/1998 | US5759827 Acylated oligopeptides for transfecting cells |
| 06/02/1998 | US5759516 Peptide-metal ion pharmaceutical preparation |
| 06/02/1998 | US5759515 Polyvalent peptide pharmaceutical applications |
| 06/02/1998 | CA1339897C Peptide boronic acid inhibitors of trypsin-like proteases |
| 05/28/1998 | WO1998022624A1 A method of detecting protein by immuno rna |
| 05/28/1998 | WO1998022494A2 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS |
| 05/28/1998 | WO1998022493A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 05/28/1998 | WO1998022125A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 05/28/1998 | CA2272095A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 05/28/1998 | CA2270876A1 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/28/1998 | CA2267634A1 Methods and compounds for inhibiting .beta.-amyloid peptide release and/or synthesis |
| 05/27/1998 | EP0843516A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 05/27/1998 | CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/27/1998 | CN1183102A Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/27/1998 | CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 05/27/1998 | CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
| 05/26/1998 | US5756832 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring |
| 05/26/1998 | US5756825 A chelating compound comprises protein conjugation function and a chelate function; the chelating compound is 3-carboxypropyl n-(tris(2-((n-(benzyloxy)amino)carbonyl)ethyl )-methyl)succinamate |
| 05/26/1998 | US5756823 Glutathione monoester sulfonate |
| 05/26/1998 | US5756758 Esterification |
| 05/26/1998 | US5756534 Retroviral protease inhibitors |
| 05/26/1998 | US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/26/1998 | US5756467 Useful in prevention and therapy of obesity and cardiovascular diseases in humans and animals; administering in food and feeds |
| 05/26/1998 | US5756466 Inhibitors of interleukin-1β converting enzyme |
| 05/26/1998 | US5756465 Protease enzyme inhibitors |
| 05/26/1998 | US5756449 Intranasal, oral, buccal, parenteal, topical, or rectal administeration or direct inhalation; atleast 4 amino acid residues or salts and atleast one of the amino acids is substituted n-alkyl amino acid |
| 05/26/1998 | US5756295 DNA primer and a method for screening DNAS |
| 05/22/1998 | WO1998021193A1 Antithrombotic organic nitrates |
| 05/22/1998 | WO1998020887A1 Polyphosphoinositide binding peptides for intracellular drug delivery |
| 05/20/1998 | EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4 |
| 05/20/1998 | EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4 |
| 05/20/1998 | EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists |
| 05/20/1998 | EP0842196A1 Cell adhesion inhibitors |
| 05/20/1998 | EP0842190A1 Process for producing dolastatin 15 and intermediates thereof |
| 05/20/1998 | EP0841918A1 Thrombin inhibitors |
| 05/20/1998 | CN1182434A Novel peptide derivatives |
| 05/19/1998 | US5753667 1-oxo-2- (phenylsulphonylamino) pentylpiperidine derivatives, their preparation and their therapeutic application |
| 05/19/1998 | US5753650 Inhibitors of farnesyl-protein transferase |
| 05/15/1998 | CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists |
| 05/15/1998 | CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists |
| 05/14/1998 | WO1998020156A1 Hydrolase binding assay |
| 05/14/1998 | WO1998020149A1 PROCESS FOR PROODUCING METHYL α-L-ASPARTYL-L-PHENYLALANINATE OR α-L-ASPARTYL-L-PHENYLALANINE |
| 05/14/1998 | WO1998020024A1 Ligands for phosphatase binding assay |
| 05/14/1998 | WO1998019705A1 Branched peptide linkers |
| 05/14/1998 | CA2269659A1 Hydrolase binding assay |
| 05/14/1998 | CA2269637A1 Ligands for phosphatase binding assay |
| 05/14/1998 | CA2264610A1 Branched peptide linkers |
| 05/13/1998 | EP0841396A1 Human telomerase catalytic subunit |
| 05/13/1998 | EP0840614A1 Calpain inhibitors for the treatment of neurodegenerative diseases |
| 05/13/1998 | CN1181755A THF-containing sulfonamide inhibitors of aspartyl protease |
| 05/12/1998 | US5750696 Dioxacycloalkane compound having renin-inhibitory activity |
| 05/12/1998 | US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors |
| 05/12/1998 | US5750665 Preparation of glucosaminyl muramic acid derivatives |
| 05/12/1998 | US5750648 Retroviral protease inhibitors and combinations thereof |
| 05/12/1998 | US5750555 Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino acid as PKC inhibitors |
| 05/12/1998 | US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/12/1998 | US5750520 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 05/12/1998 | US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
| 05/12/1998 | CA2010312C Peptide derivatives and their pharmaceutical use |
| 05/07/1998 | WO1998018815A1 Convergent process for the preparation of a growth hormone secretagogue |
| 05/07/1998 | WO1998018794A1 Novel heterocyclic amide compounds and medicinal uses thereof |
| 05/07/1998 | WO1998018763A1 Tetrahydroisoquinoline derivatives |
| 05/07/1998 | WO1998009985A3 Anti-inflammatory peptides and uses thereof |
| 05/07/1998 | WO1998003537A3 Hirustasin and a hirustasin/kallikrein complex in crystalline form |
| 05/07/1998 | CA2269720A1 Novel heterocyclic amide compound and pharmaceutical use thereof |
| 05/06/1998 | EP0839828A1 Building blocks for DNA/PNA-Cooligomer |
| 05/06/1998 | EP0839798A2 Intermediates for preparating non-peptide retroviral protease inhibitors |
| 05/06/1998 | EP0839155A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 05/06/1998 | EP0839154A1 Biologically active peptides and compositions, their use |
| 05/06/1998 | EP0839153A1 Process of preparation of peptides and n-carbamoyl protected peptides |
| 05/05/1998 | US5747504 Administering n-alanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as hypotensive agents |
| 05/05/1998 | US5747460 Method of treatment and prophylaxis of venous thrombosis |
| 05/05/1998 | US5747458 Plasminogen activator of protease and tripeptides |
| 05/05/1998 | US5747457 Linear adhesion inhibitors |
| 05/05/1998 | US5747304 Fungicidal agents LL-15G256γ,δ, and ε produced by LL-15G256 (Hypoxylon oceanicum) |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747295 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T |
| 04/30/1998 | WO1998017680A1 Peptide analogues containing a 7-membered lactam ring |
| 04/30/1998 | WO1998017679A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 04/30/1998 | WO1998017678A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 04/30/1998 | WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |